Cargando…

Multiple sclerosis, B cell therapy, and the COVID-19 vaccine

Detalles Bibliográficos
Autor principal: Seachrist, Eric J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826102/
https://www.ncbi.nlm.nih.gov/pubmed/33521339
http://dx.doi.org/10.1016/j.ensci.2021.100319
_version_ 1783640462298447872
author Seachrist, Eric J.
author_facet Seachrist, Eric J.
author_sort Seachrist, Eric J.
collection PubMed
description
format Online
Article
Text
id pubmed-7826102
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78261022021-01-25 Multiple sclerosis, B cell therapy, and the COVID-19 vaccine Seachrist, Eric J. eNeurologicalSci Letter to the Editor Elsevier 2021-01-21 /pmc/articles/PMC7826102/ /pubmed/33521339 http://dx.doi.org/10.1016/j.ensci.2021.100319 Text en © 2021 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Seachrist, Eric J.
Multiple sclerosis, B cell therapy, and the COVID-19 vaccine
title Multiple sclerosis, B cell therapy, and the COVID-19 vaccine
title_full Multiple sclerosis, B cell therapy, and the COVID-19 vaccine
title_fullStr Multiple sclerosis, B cell therapy, and the COVID-19 vaccine
title_full_unstemmed Multiple sclerosis, B cell therapy, and the COVID-19 vaccine
title_short Multiple sclerosis, B cell therapy, and the COVID-19 vaccine
title_sort multiple sclerosis, b cell therapy, and the covid-19 vaccine
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826102/
https://www.ncbi.nlm.nih.gov/pubmed/33521339
http://dx.doi.org/10.1016/j.ensci.2021.100319
work_keys_str_mv AT seachristericj multiplesclerosisbcelltherapyandthecovid19vaccine